ETRA Electra Therapeutics, Inc.

Fundamentals / CIK 0002088082 / USD

Electra Therapeutics, Inc. reported $410.8M in total assets through September 30, 2026 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ETRA in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

No annual income statement rows are available in SEC EDGAR CompanyFacts for ETRA.

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-09-30 2025-06-30 2025-03-31
Research & Development $17.27M -- -- $14.90M -- --
Total Operating Expenses $25.06M -- -- $17.02M -- --
Operating Income -$25.06M -- -- -$17.02M -- --
Interest Income $1.13M -- -- $232K -- --
Interest Expense $0 -- -- $1.30M -- --
Net Income -$23.93M -$26.75M -$22.17M -$18.09M -$17.57M -$7.79M
Basic EPS -$3.47 -- -- -$616.86 -- --
Diluted EPS -$3.47 -- -- -$616.86 -- --
Basic Shares Outstanding 6.9M -- -- 29.3K -- --
Diluted Shares Outstanding 6.9M -- -- 29.3K -- --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

No annual balance sheet rows are available in SEC EDGAR CompanyFacts for ETRA.

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2025-12-31
Cash & Cash Equivalents $256.4M $33.01M
Short-Term Investments $146.1M $53.51M
Cash & Short-Term Investments $402.5M $86.52M
Total Current Assets $406.9M $95.49M
Property, Plant & Equipment, Net $518K $674K
Other Non-Current Assets $1.80M $1.10M
Total Non-Current Assets $3.89M $3.88M
Total Assets $410.8M $99.37M
Accounts Payable $8.06M $4.08M
Total Current Liabilities $16.98M $9.73M
Long-Term Debt $0 --
Total Non-Current Liabilities $939K $1.48M
Total Liabilities $17.92M $11.21M
Total Debt (incl. Leases) $1.71M $2.09M
Common Stock $6.0K $0
Retained Earnings -$245.8M -$173.0M
Accumulated Other Comp. Income $13K $21K
Total Stockholders' Equity $392.9M -$163.4M
Total Equity $392.9M -$163.4M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

No annual cash flow statement rows are available in SEC EDGAR CompanyFacts for ETRA.

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-09-30 2025-06-30 2025-03-31
Net Income -$23.93M -$26.75M -$22.17M -$18.09M -$17.57M -$7.79M
Stock-Based Compensation $4.59M -- -- $302K -- --

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

No annual ratios & growth rows are available in SEC EDGAR CompanyFacts for ETRA.

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-09-30 2025-06-30 2025-03-31
Current Ratio 23.97x -- -- -- -- --
Quick Ratio 23.71x -- -- -- -- --
Debt to Equity 0.00x -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0002088082) · from March 31, 2025 Data through September 30, 2026 · synced Nov 20, 2026, 05:45 UTC · Open in terminal